"11110" . "14"^^ . "RIV/00216208:11110/12:12631!RIV13-MSM-11110___" . "Efficacy of disease modifying drugs (sulfasalazin and methotrexate) as co-therapy with rituximab. Analysis of 10 European registries. Concentration on long term results, survival on therapy and outcomes dealing with quality of life." . . . . "Chatzidionysiou, Katerina" . "rheumatoid arthritis; biologic therapy; rituximab"@en . "Gomez-Reino, Juan" . "Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration"@en . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "1"^^ . . "Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration"@en . . "Gabay, C." . "van Riel, Piet L. C. M." . "Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration" . . . "000300039700011" . "Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration" . "van Vollenhoven, R. F." . "V" . "Lukina, Galina" . . "Nasonov, Evgeny" . . "Pavelka, Karel" . . "Annals of Rheumatic Diseases" . "Tomsic, M." . "4"^^ . "0003-4967" . "3" . "Tarp, Ulrik" . . "133398" . "Lie, Elisabeth" . "http://dx.doi.org/10.1136/annrheumdis-2011-200003" . "RIV/00216208:11110/12:12631" . "71" . . . . "Hetland, Merete Lund" . "Kvien, T. K." . . "Nordstrom, Dan C." . "[6B3FC6060587]" . "Efficacy of disease modifying drugs (sulfasalazin and methotrexate) as co-therapy with rituximab. Analysis of 10 European registries. Concentration on long term results, survival on therapy and outcomes dealing with quality of life."@en .